Overexpression of p53 tumor suppressor protein in porokeratosis. Read more about Overexpression of p53 tumor suppressor protein in porokeratosis.
Interface dermatitis. How specific are its histopathologic features? Read more about Interface dermatitis. How specific are its histopathologic features?
Lymphomatoid papulosis followed by Hodgkin's lymphoma. Differential response to therapy. Read more about Lymphomatoid papulosis followed by Hodgkin's lymphoma. Differential response to therapy.
Nonmelanoma skin cancers and infection with the human immunodeficiency virus. Read more about Nonmelanoma skin cancers and infection with the human immunodeficiency virus.
Acrodermatitis enteropathica in a patient with the acquired immunodeficiency syndrome. Read more about Acrodermatitis enteropathica in a patient with the acquired immunodeficiency syndrome.
Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Read more about Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection.
The expanding spectrum of a new disease, bacillary angiomatosis. Read more about The expanding spectrum of a new disease, bacillary angiomatosis.
Bacillary (epithelioid) angiomatosis and concurrent Kaposi's sarcoma in acquired immunodeficiency syndrome. Read more about Bacillary (epithelioid) angiomatosis and concurrent Kaposi's sarcoma in acquired immunodeficiency syndrome.
Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation. Read more about Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
Glucose and insulin responses are improved in patients with psoriasis during therapy with etretinate. Read more about Glucose and insulin responses are improved in patients with psoriasis during therapy with etretinate.
